Janux Property Plant And Equipment Gross from 2010 to 2025

JANX Stock  USD 32.60  0.09  0.28%   
Janux Therapeutics Property Plant And Equipment Gross yearly trend continues to be fairly stable with very little volatility. Property Plant And Equipment Gross is likely to outpace its year average in 2025. During the period from 2010 to 2025, Janux Therapeutics Property Plant And Equipment Gross regression line of annual values had r-squared of  0.59 and arithmetic mean of  8,411,682. View All Fundamentals
 
Property Plant And Equipment Gross  
First Reported
2010-12-31
Previous Quarter
35.4 M
Current Value
37.1 M
Quarterly Volatility
14.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Janux Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Janux Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 15.1 M, Depreciation And Amortization of 2.4 M or Interest Expense of 4.9 M, as well as many indicators such as Price To Sales Ratio of 127, Dividend Yield of 0.0 or PTB Ratio of 1.3. Janux financial statements analysis is a perfect complement when working with Janux Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Janux Therapeutics Correlation against competitors.
For more information on how to buy Janux Stock please use our How to Invest in Janux Therapeutics guide.

Latest Janux Therapeutics' Property Plant And Equipment Gross Growth Pattern

Below is the plot of the Property Plant And Equipment Gross of Janux Therapeutics over the last few years. It is Janux Therapeutics' Property Plant And Equipment Gross historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Janux Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Gross10 Years Trend
Slightly volatile
   Property Plant And Equipment Gross   
       Timeline  

Janux Property Plant And Equipment Gross Regression Statistics

Arithmetic Mean8,411,682
Geometric Mean196,392
Coefficient Of Variation176.56
Mean Deviation12,372,273
Median21,000
Standard Deviation14,851,924
Sample Variance220.6T
Range37.1M
R-Value0.77
Mean Square Error96.8T
R-Squared0.59
Significance0.0005
Slope2,397,237
Total Sum of Squares3308.7T

Janux Property Plant And Equipment Gross History

202537.1 M
202435.4 M
202330.8 M
202229.4 M
20211.6 M
2020155 K

About Janux Therapeutics Financial Statements

Janux Therapeutics investors use historical fundamental indicators, such as Janux Therapeutics' Property Plant And Equipment Gross, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Janux Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Property Plant And Equipment Gross35.4 M37.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Janux Stock Analysis

When running Janux Therapeutics' price analysis, check to measure Janux Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Janux Therapeutics is operating at the current time. Most of Janux Therapeutics' value examination focuses on studying past and present price action to predict the probability of Janux Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Janux Therapeutics' price. Additionally, you may evaluate how the addition of Janux Therapeutics to your portfolios can decrease your overall portfolio volatility.